Literature DB >> 18680671

Hepatitis E virus genotype 1, Cuba.

María de la Caridad Montalvo Villalba, Licel de Los Angeles Rodríguez Lay, Vivek Chandra, Marité Bello Corredor, Susel Sariego Frometa, Aidonis Gutierrez Moreno, Shahid Jameel.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18680671      PMCID: PMC2600407          DOI: 10.3201/eid1408.080049

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Hepatitis E virus (HEV) causes acute viral hepatitis, which in rare cases leads to fulminant hepatitis with high death rates, especially among women in their third trimester of pregnancy (). Sporadic infections and epidemics have been reported from all parts of the world, especially Asia, Africa, and Latin America. Although indigenous hepatitis E has rarely been observed in industrialized countries, higher than expected anti-HEV prevalence has been detected in these areas (). In the Caribbean region, many countries including Cuba, Haiti, Guatemala, and Honduras have reported hepatitis E (,), but the viruses have not been characterized. The transmission of HEV is primarily fecal–oral, through contaminated drinking water; limited zoonotic transmission has also been reported. Despite only 1 serotype, 4 major genotypes of HEV have been reported (). Genotype 1 is mainly responsible for sporadic infections and large outbreaks in Asia and Africa. Genotype 2 was first found in Mexico and later on the African continent. Genotypes 3 and 4 have been reported from the United States, Europe, China, Japan, and Taiwan; this group also includes the related swine HEV (). We report the phylogenetic analysis of 11 HEV isolates from 2 outbreaks and sporadic cases in Havana, Cuba. The first outbreak occurred in 1999 in a factory; 20 persons were affected (12 women, 8 men; median age 45 years, range 22–53 years). The second outbreak was in 2005 in a suburb of Havana and involved 26 persons (15 women, 11 men; median age 24 years, range 17–45 years). We also analyzed HEV in 12 sporadic clinical cases obtained from the Cuban national surveillance program for viral hepatitis. Most patients reported asthenia, epigastric pain, nausea, and vomiting. None had any history of international travel, contact with persons traveling from disease-endemic areas, or consumption of exotic foods. Serologic screening showed all patients to be negative for immunoglobulin (Ig) M against hepatitis A and hepatitis C viruses. One patient had positive results for hepatitis B surface antigen but negative results for anti-hepatitis B core antigen IgM and hepatitis B virus DNA. All patients were positive for anti-HEV IgM (Genelab Diagnostics, Singapore) according to the manufacture’s criteria. A total of 22 serum samples (outbreak 1, n = 9; outbreak 2, n = 7; sporadic cases, n = 6) were tested for HEV RNA; only 2 (both from sporadic cases) were positive. A total of 31 serum samples were also tested for anti-HEV IgG (Genelab Diagnostics), of which 22 were positive (outbreak 1, n = 7/10; outbreak 2, n = 10/13; sporadic cases, n = 5/8). A total of 44 stool samples were collected 2–4 weeks after onset of symptoms and stored at –70°C until use. Fecal samples were screened for HEV open reading frame (ORF) 2 by using reverse transcription (RT)–PCR (). For genotyping, nested RT-PCR was then performed for the ORF1 RdRp region () on 18 samples that were positive for ORF2. Of the 12 PCR products obtained, 11 fragments were cloned into pGEMT Easy Vector (Promega, Madison, WI, USA). At least 3 positive clones for each sample were sequenced, and the consensus sequence was used for phylogenetic analysis. The GenBank accession numbers of ORF1 for the HEV outbreak cases from Cuba are CUB10-1999 (EU165504), CUB11-1999 (EU165502), CUB13-1999 (EU1655019), CUB19-1999 (EU165500), CUB24-1999 (EU165499), CUB68-2005 (EU165496), and CUB71-2005 (EU165495). For the sporadic cases they are CUB9-2005 (EU165503), CUB1803-2003 (EU165494), CUB2-2005 (EF493155), and CUB27-2005 (EU165498). Additionally, nested RT-PCR was conducted with ORF2-specific primer pairs () for 2 HEV isolates, 1 each from outbreak and sporadic cases, and sequences were obtained. The accession numbers for ORF2 are outbreak CUB10D-1999 (EU284749) and sporadic CUB2D-2005 (EU284748). Phylogenetic analysis of ORF1 nucleotide sequences showed that HEV isolates from Cuba clustered in genotype 1 with high bootstrap values (Figure, panel A). The same genotype was detected in an outbreak of hepatitis E in UN peacekeepers deployed from Bangladesh to Haiti (). Although the outbreak was adequately contained, anti-HEV immunoglobulin was subsequently detected in 3% of civilians in Haiti (). Nucleotide identity between isolates from Cuba and other HEV strains from genotype 1 ranged from 91.7% to 99%. The strains from Cuba were closely related to the isolates from India and shared 97.8%–99% homology with Yam-67 (). Absolute ORF1 nucleotide differences (p-distances; MEGA2 software, www.megasoftware.net) of isolates from Cuba ranged from 0% to 1.6%, demonstrating a high degree of relatedness. The ORF2 analysis supported our ORF1 findings because the CUB2D-2005 and CUB10D-1999 sequences also clustered with genotype 1 (Figure, panel B). Both strains from Cuba shared 96.1% nucleotide homology with a prototype strain from Burma (Bur82) and were related to the strains from India (Hyderabad and Yam-67), sharing 97.4%–99% homology. Absolute ORF2 nucleotide differences ranged from 0.8% to 1.9%. This value for ORF1 ranged from 0.05% to 0.08% for the same isolates from Cuba (CUB2-2005 and CUB10-1999).
Figure

Phylogenetic trees constructed on the basis of A) 240 nucleotides, RdRp region, from open reading frame (ORF) 1, and B) 311 nucleotides from ORF2. Each tree was generated by using the neighbor-joining method; the distance matrix was calculated by using the Kimura 2-parameter method. The robustness of the trees was determined by bootstrap for 1,000 replicates. Values >70% are shown at the nodes. The major branches represent hepatitis E virus genotypes. Scale bar indicates 0.05 substitutions per nucleotide position.

Phylogenetic trees constructed on the basis of A) 240 nucleotides, RdRp region, from open reading frame (ORF) 1, and B) 311 nucleotides from ORF2. Each tree was generated by using the neighbor-joining method; the distance matrix was calculated by using the Kimura 2-parameter method. The robustness of the trees was determined by bootstrap for 1,000 replicates. Values >70% are shown at the nodes. The major branches represent hepatitis E virus genotypes. Scale bar indicates 0.05 substitutions per nucleotide position. HEV shows a global presence. The genotype distribution, although dominant in a given geographic area, is not limited to that area. For example, genotype 2, first identified on the American continent in Mexico (), was later found in Namibia and Nigeria on the African continent (,). We report indigenous HEV genotype 1 strains in the Americas.
  10 in total

1.  Hepatitis E virus in Cuba.

Authors:  G Lemos; S Jameel; S Panda; L Rivera; L Rodríguez; J V Gavilondo
Journal:  J Clin Virol       Date:  2000-02       Impact factor: 3.168

2.  Identification of a novel hepatitis E virus in Nigeria.

Authors:  Y Buisson; M Grandadam; E Nicand; P Cheval; H van Cuyck-Gandre; B Innis; P Rehel; P Coursaget; R Teyssou; S Tsarev
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

3.  Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV.

Authors:  G G Schlauder; S M Desai; A R Zanetti; N C Tassopoulos; I K Mushahwar
Journal:  J Med Virol       Date:  1999-03       Impact factor: 2.327

4.  Reevaluation of a North India isolate of hepatitis E virus based on the full-length genomic sequence obtained following long RT-PCR.

Authors:  Shahid Jameel; Mohammad Zafrullah; Yogesh K Chawla; Jang B Dilawari
Journal:  Virus Res       Date:  2002-06       Impact factor: 3.303

Review 5.  Hepatitis E virus.

Authors:  Suzanne U Emerson; Robert H Purcell
Journal:  Rev Med Virol       Date:  2003 May-Jun       Impact factor: 6.989

6.  Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995.

Authors:  Hazel T Maila; Sheila M Bowyer; Robert Swanepoel
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

7.  Hepatitis E virus genotyping based on full-length genome and partial genomic regions.

Authors:  Lijie Zhai; Xing Dai; Jihong Meng
Journal:  Virus Res       Date:  2006-02-10       Impact factor: 3.303

8.  Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV).

Authors:  C C Huang; D Nguyen; J Fernandez; K Y Yun; K E Fry; D W Bradley; A W Tam; G R Reyes
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

9.  Seroprevalence of hepatitis E virus among United Nations Mission in Haiti (UNMIH) peacekeepers, 1995.

Authors:  J M Gambel; J J Drabick; J Seriwatana; B L Innis
Journal:  Am J Trop Med Hyg       Date:  1998-06       Impact factor: 2.345

10.  Hepatitis E virus transmission from wild boar meat.

Authors:  Tian-Cheng Li; Katsumi Chijiwa; Nobuyuki Sera; Tetsuya Ishibashi; Yoshiki Etoh; Yuji Shinohara; Yasuo Kurata; Miki Ishida; Shigeru Sakamoto; Naokazu Takeda; Tatsuo Miyamura
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

  10 in total
  10 in total

1.  Seroprevalence of seven zoonotic pathogens in pregnant women from the Caribbean.

Authors:  Heidi Wood; Michael A Drebot; Eric Dewailly; Liz Dillon; Kristina Dimitrova; Martin Forde; Allen Grolla; Elise Lee; Amanda Loftis; Kai Makowski; Karen Morrison; Lyndon Robertson; Rosina C Krecek
Journal:  Am J Trop Med Hyg       Date:  2014-06-09       Impact factor: 2.345

2.  Seroprevalence of Hepatitis A and Hepatitis E Viruses among Pregnant Women in Haiti.

Authors:  Alexandra Tejada-Strop; Rania A Tohme; Jocelyne Andre-Alboth; Lana Childs; Xin Ji; Vivianne de Oliveira Landgraf de Castro; Jacques Boncy; Saleem Kamili
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

Review 3.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 4.  Epidemiology of Genotype 1 and 2 Hepatitis E Virus Infections.

Authors:  Kenrad E Nelson; Alain B Labrique; Brittany L Kmush
Journal:  Cold Spring Harb Perspect Med       Date:  2019-06-03       Impact factor: 6.915

5.  Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis.

Authors:  Nathalie Verónica Fernández Villalobos; Barbora Kessel; Isti Rodiah; Jördis Jennifer Ott; Berit Lange; Gérard Krause
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

6.  High prevalence of hepatitis E in humans and pigs and evidence of genotype-3 virus in swine, Madagascar.

Authors:  Sarah Temmam; Lydia Besnard; Soa Fy Andriamandimby; Coralie Foray; Harentsoaniaina Rasamoelina-Andriamanivo; Jean-Michel Héraud; Eric Cardinale; Koussay Dellagi; Nicole Pavio; Hervé Pascalis; Vincent Porphyre
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

Review 7.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

Review 8.  Epidemiology of Hepatitis E Virus in European Countries.

Authors:  Daniele Lapa; Maria Rosaria Capobianchi; Anna Rosa Garbuglia
Journal:  Int J Mol Sci       Date:  2015-10-27       Impact factor: 5.923

9.  First evidence of the Hepatitis E virus in environmental waters in Colombia.

Authors:  Paula A Baez; Maria Camila Lopez; Alejandra Duque-Jaramillo; Dioselina Pelaez; Francisco Molina; Maria-Cristina Navas
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

Review 10.  Hepatitis E Virus: An emerging enigmatic and underestimated pathogen.

Authors:  Yakubu Egigogo Raji; Ooi Peck Toung; Niazlin Mohd Taib; Zamberi Bin Sekawi
Journal:  Saudi J Biol Sci       Date:  2021-09-20       Impact factor: 4.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.